Ticozid T 250mg/31.25mg Injection
Marketer
Asiatic Pharmaceuticals
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Ticozid T 250mg/31.25mg Injection
Combiflox 250mg/31.25mg Injection is a dual-action antibiotic, indicated for diverse bacterial infections. This medication combats microbial proliferation, curbing infection spread. Administration must be overseen by a medical professional. Strictly adhere to the prescribed dosage schedule; complete the full course, regardless of symptom improvement. Premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; consult your physician if these worsen. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving is discouraged if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor treatment response.
Uses of Ticozid T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ticozid T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ticozid T 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Ticozid T 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Ticozid T 250mg/31.25mg Injection works:
Ticozid T Injection (250mg/31.25mg) combines the antibiotic Ceftazidime with the beta-lactamase inhibitor Tazobactum. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance, thus boosting Ceftazidime's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Ticozid T 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Ticozid T 250mg/31.25mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation is not contraindicated with Ticozid T 250mg/31.25mg Injection. Research in humans indicates negligible transfer into breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Administering Ticozid T 250mg/31.25mg Injection could reduce vigilance, impair vision, and induce drowsiness or dizziness. Driving is prohibited should these effects manifest.
KidneyCAUTION
For individuals with impaired kidney function, administration of Ticozid T 250mg/31.25mg Injection requires careful monitoring. Dosage modification of Ticozid T 250mg/31.25mg Injection might be necessary. Medical advice should be sought.
LiverCAUTION
Patients with severe hepatic impairment should use Ticozid T 250mg/31.25mg Injection cautiously, potentially requiring dosage modification. Medical advice is recommended.
What if you forget to take Ticozid T 250mg/31.25mg Injection :
Omit a Ticozid T 250mg/31.25mg Injection dose? Seek your physician's advice.
Facts to Know About Ticozid T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently